Zika Virus Vaccines


The live-attenuated vaccine is developed for the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, the definition of E dimers as the key antigenic target, and a deep understanding of neutralization mechanisms help to develop the vaccine.


    Related Conference of Zika Virus Vaccines

    July 13-14, 2022

    Annual World Retro Virus and Gene Transfer Conference

    London, UK
    July 25-26, 2022

    6th International Conference on Vaccines and Immunology

    Paris, France
    July 28-29, 2022

    5th International Conference on Antimicrobial and Antibacterial Agents

    London, UK
    August 10-11, 2022

    International conference on Vaccinces, Vaccination and Immunization

    Paris, France
    August 22-23, 2022

    4th World Congress on Vaccine and Immunology

    Toronto, Canada
    September 05-06, 2022

    42nd Global Summit and Expo on Vaccines & Immunology

    Paris, France
    October 05-06, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland
    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany
    March 23-24, 2023

    6th International Conference on Vaccines, Immunology and Clinical Trials

    Amsterdam, Netherlands

    Zika Virus Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in